Centreva

Centreva is mainly engaged in the research, development, production and sales of animal health products. Committed to safeguarding food safety, the company insists on using natural plants as raw materials to avoid drug residues, thereby improving the safety of animal-derived food and promoting human health. The company's products mainly cover four major categories: veterinary traditional Chinese medicine preparations, veterinary chemical preparations, veterinary biological products, and premixed feed. It is one of the few animal health enterprises in China with independent R&D capabilities and leading technical advantages in both veterinary traditional Chinese medicine preparations and veterinary biological products, especially in the field of veterinary traditional Chinese medicine, where the company holds a leading position. Up to now, the company has obtained new veterinary drug certificates for 16 veterinary traditional Chinese medicine products, including Astragalus polysaccharide powder and Astragalus polysaccharide oral liquid, and new veterinary drug certificates for 3 veterinary biological products: "Mycoplasma hyopneumoniae inactivated vaccine," "Newcastle disease and avian influenza (H9 subtype) bivalent inactivated vaccine (La Sota strain + JD strain)," and "Pseudorabies heat-resistant protective agent live vaccine." In addition, the company has obtained a total of 15 authorized patents, including 10 invention patents. 1. Recruitment department: Human Resources Center 2. Person in charge: Chen Xueshu 3. Resume email: cxsbrave@* 4. Company website: * 5. Company address: No. 44 Yongda Road, Biomedical Base, Daxing District, Beijing